Global Induced Pluripotent Stem Cell (iPSC) Industry
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Based Clinical Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The
/PRNewswire/ -- The "The Global Exosome Market - Market Size, Forecast, Trials, and Trends, 2023" report has been added to ResearchAndMarkets.com's offering....
DUBLIN--(BUSINESS WIRE)--The "The Global Exosome Market - Market Size, Forecast, Trials, and Trends, 2023" report has been added to ResearchAndMarkets.com's offering.Globally, there are at least 204 clinical trials focusing on exosome-related studies. Of these, 114 trials are evaluating exosome-based therapeutics an...
Having scheduled check-ins for an ongoing trial arguably helps patients feel more informed and in charge of their health.
Share this article Share this article ResearchAndMarkets.com's offering. Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into a variety of cell types, including but not limited to osteoblasts, chondrocytes, myocytes, and adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cell types for a variety of reasons, including that they are immuno-privileged, making them an advantageous cel...